Concepedia

Publication | Open Access

PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis

16

Citations

6

References

2021

Year

Abstract

Findings from this proof-of-concept study may support further development and evaluation of PF-06730512 to treat FSGS and warrant assessment in phase 3 clinical trials.

References

YearCitations

Page 1